Free Trial

Insider Selling: CareCloud, Inc. (NASDAQ:CCLD) Director Sells 15,000 Shares of Stock

CareCloud logo with Medical background

CareCloud, Inc. (NASDAQ:CCLD - Get Free Report) Director John N. Daly sold 15,000 shares of CareCloud stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $2.11, for a total value of $31,650.00. Following the transaction, the director now owns 61,750 shares in the company, valued at $130,292.50. This represents a 19.54% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

CareCloud Stock Up 7.2%

Shares of NASDAQ:CCLD traded up $0.17 during trading on Wednesday, reaching $2.52. 1,481,573 shares of the company traded hands, compared to its average volume of 383,738. The firm has a fifty day simple moving average of $1.90 and a 200 day simple moving average of $2.62. CareCloud, Inc. has a 1-year low of $1.14 and a 1-year high of $4.84. The firm has a market cap of $106.65 million, a P/E ratio of -11.45 and a beta of 2.05.

CareCloud (NASDAQ:CCLD - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). The firm had revenue of $27.60 million for the quarter, compared to analysts' expectations of $25.94 million. CareCloud had a return on equity of 24.08% and a net margin of 8.92%. As a group, research analysts anticipate that CareCloud, Inc. will post 0.58 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CCLD. Roth Capital restated a "neutral" rating on shares of CareCloud in a research report on Tuesday, May 6th. Roth Mkm reissued a "neutral" rating and issued a $1.50 price target (down from $3.50) on shares of CareCloud in a research report on Friday, March 14th.

View Our Latest Stock Report on CCLD

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of CCLD. Empowered Funds LLC lifted its holdings in shares of CareCloud by 51.2% during the 4th quarter. Empowered Funds LLC now owns 61,240 shares of the company's stock valued at $224,000 after buying an additional 20,750 shares during the last quarter. Hillsdale Investment Management Inc. acquired a new position in CareCloud in the fourth quarter worth approximately $252,000. Heron Bay Capital Management raised its position in CareCloud by 48.5% during the fourth quarter. Heron Bay Capital Management now owns 101,119 shares of the company's stock valued at $370,000 after acquiring an additional 33,033 shares in the last quarter. Renaissance Technologies LLC raised its position in CareCloud by 7.0% during the fourth quarter. Renaissance Technologies LLC now owns 124,100 shares of the company's stock valued at $454,000 after acquiring an additional 8,100 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in CareCloud by 31.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 15,096 shares of the company's stock valued at $55,000 after acquiring an additional 3,641 shares during the last quarter. 10.16% of the stock is owned by institutional investors and hedge funds.

About CareCloud

(Get Free Report)

CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CareCloud Right Now?

Before you consider CareCloud, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CareCloud wasn't on the list.

While CareCloud currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines